Drug Product
Analytical & Bioanalytical Services
Regulatory, Tech Transfer & Support Services
Company Overview
About
NCK A/S (Niels Clauson-Kaas) is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Biologics Manufacturing, Monoclonal Antibodies, Vaccines
Therapeutic Areas
Cardiovascular
Endocrinology
Quick Facts
HQ:Denmark
Founded:2006
Employees:467
Capabilities & Services
Core Capabilities
- Sterile Injectable
- Sterile Fill/Finish
- Fill/Finish (Vials)
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Cartridge / Pen
Containment Capabilities
OEB 5 (≤1 µg/m³)
Cytotoxic / ADC Handling
Production Scales
R&D / Pre-clinical
Lab Scale
Pilot Scale
Markets Served
Asia-Pacific
International Regulatory
EU GMP Certificates
5
Regulatory Bodies
EMA/EudraGMDP
Regulatory Approvals
Drug Approval RDYFW4
PMDA · #APR-8YNKXM6E · 2018-11-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-MIPL9UCV
Issued: 2020-04-03
Expires: 2025-06-28
Health Canada GMP
Health Canada
Cert #: CERT-BXW1IJ3T
Issued: 2020-03-23
Expires: 2025-07-23
Loading CDMO intelligence...
Key facts about NCK A/S (Niels Clauson-Kaas)
- NCK A/S (Niels Clauson-Kaas) is headquartered in Denmark.
- NCK A/S (Niels Clauson-Kaas) was founded in 2006.
- NCK A/S (Niels Clauson-Kaas) has 467 employees.
- NCK A/S (Niels Clauson-Kaas)'s capabilities include Sterile Injectable, Sterile Fill/Finish and Fill/Finish (Vials).
Find CDMOs like NCK A/S (Niels Clauson-Kaas)
Directory pages this company appears in, each with the full list of matching manufacturers.